Associate Professor, Medicine, Case Western Reserve University School of Medicine
Infectious Disease
Dr. Sherif B. Mossad, MD
|
|
Give Review
Sherif Mossad works in the field of Infectious Disease. He studied medicine at Cairo University School of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification". Dr. Sherif B. Mossad is also a published physician. He has 72 paper published. The most recent paper is: Underused options for preventing and treating influenza. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation.
- Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections.
- Transient versus Persistent BK Viremia and Long-Term Outcomes after Kidney and Kidney-Pancreas Transplantation.
- Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplant.
- Epidemiology and risk factors for infections in myelodysplastic syndromes.
- CMV Viremia Is Associated With a Decreased Incidence of BKV Reactivation after Kidney and Kidney-Pancreas Transplantation.
- The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation.
- Contrasting patterns of viral load response in transplant recipients with BK polyomavirus DNAemia on leflunomide therapy.
- 2012-2013 influenza update: hitting a rapidly moving target.
- Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation.
- Fatal human metapneumovirus and influenza B virus coinfection in an allogeneic hematopoietic stem cell transplant recipient.
- Region-specific challenges to minimize donor-transmitted endemic infections.
- Preventing CMV viremia and disease 3-6 months after renal transplantation.
- Utility of leflunomide in the treatment of complex cytomegalovirus syndromes.
- Influenza in long-term care facilities: preventable, detectable, treatable.
- The first pandemic of the 21st century: a review of the 2009 pandemic variant influenza A (H1N1) virus.
- Disseminated fusariosis in a recipient of a bone-marrow transplant.
- The resurgence of swine-origin influenza A (H1N1).
- 2008-2009 Influenza update: a better vaccine match.
- Agranulocytosis induced by nonchemotherapy drugs.
- Influenza update 2007-2008: vaccine advances, pandemic preparation.
- Which agents should we use to treat and prevent influenza in 2006-2007?
- Avian influenza: an emerging pandemic threat.
- Influenza 2005-2006: vaccine supplies adequate, but bird flu looms.
- Coping with the influenza vaccine shortage.
- Cell-mediated immune response to influenza vaccination in lung transplant recipients.
- Demystifying FluMist, a new intranasal, live influenza vaccine.
- Tonsillectomy in adults: a paucity of data.
- Prevention and treatment of fungal infections in bone marrow transplantation.
- Importance of antifungal prophylaxis in patients who received a nonmyeloablative allogeneic PBSC transplant.
- Pneumonitis associated with the use of mycophenolate mofetil.
- How do you manage a healthy, asymptomatic, 24-year-old with a positive RPR on a premarital blood test?
- High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients.
- Hepatitis A infection mimicking adult onset Still''s disease.
- Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection.
- Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course.
- Baker's cyst infection: case report and review.
- Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection.
- Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults.
- The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization.
- The humoral immune response to influenza vaccination in lung transplant patients.
- Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantation.
- Diagnosis: progressive multifocal leukoencephalopathy.
- Prophylactic and symptomatic treatment of influenza. Current and developing options.
- Influenza in the older adult. Indications for the use of vaccine and antiviral therapy.
- The world''s first case of Serratia liquefaciens intravascular catheter-related suppurative thrombophlebitis and native valve endocarditis.
- Pulmonary mucormycosis: the last 30 years.
- Underused options for preventing and treating influenza.
- Another look at a meta-analysis of zinc salts lozenges and the common cold.
- Significance of positive cultures from donor left atrium and postpreservation fluid in heart transplantation.
- Zinc and the common cold: are we close to a cure?
- Diagnosis: Capnocytophaga canimorsus septicemia.
- Coagulase-negative staphylococcal sternal wound infections after open heart operations.
- Sternotomy infection with Mycoplasma hominis: a cause of "culture negative" wound infection.
- Early infectious complications in autologous bone marrow transplantation: a review of 219 patients.
- Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study.
- Case report of Streptomyces endocarditis of a prosthetic aortic valve.
- HCV in Egypt in 1977.
- Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection.
- Mycobacterium fortuitum osteomyelitis in a peripheral blood stem cell transplant recipient.
- Isolated primary hepatic lymphoma in a patient with acquired immunodeficiency syndrome.
- Antiviral agents for treating influenza.
- Infections following peripheral blood progenitor cell transplantation.
- Second look at leflunomide "failure" to control cytomegalovirus infection in the setting of renal failure.
- Management of an epidural abscess after continuous epidural catheter infusion.
- Larger dose of intradermal influenza vaccination may be more immunogenic in transplant recipients.
- Influenza A/H1N1 2009 pneumonia in kidney transplant recipients: characteristics and outcomes following high-dose oseltamivir exposure.
- Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immu...
- Common infections in clinical practice: dealing with the daily uncertainties.
- Current and future therapeutic approaches to the common cold.
- Influenza A and Influenza B virus infections in the same season: how unlucky can a bone marrow transplant recipient be?
Schools
KasrElAini University
Cleveland Clinic Foundation
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Choice Plus POS II
- American Republic
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- CareSource
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- GEHA
- HealthSmart
- Choice Care PPO
- Kaiser Permanente
- Medicaid
- Medical Mutual of Ohio POS
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- MVP Health Care
- NGS CoreSource
- Principal Life
- Simplifi
- Thrivent Financial
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Univera Healthcare
- WellCare
- Wells Fargo Insurance
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Cleveland Clinic Foundation -
Cairo University School of Medicine
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1851355788 | |
| NPPES Provider LastName | MOSSAD | |
| NPPES Provider FirstName | SHERIF | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 65.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1851355788 |
| Last Name Of The Provider | MOSSAD |
| First Name Of The Provider | SHERIF |
| View All |
Similar Doctors
|
|
Dr. Robert A. Bonomo, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Robin K. Avery, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan Jay Taege, MD |
|
|
Dr. Kyle D. Brizendine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher L. King, MD |
|
|
Dr. James W. Kazura, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Michelle V. Lisgaris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter M. Wiest, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Charles H. King, MD |
|
Dr. Marta N. Jakubowycz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven K. Schmitt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abiola V. Fashanu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth P. Harausz, MD
This Doctor is OpenDoctor Recommended.
|